PARTNERS

BILL & MELINDA GATES FOUNDATION

We are partnering to develop a large animal neuroclinical pipeline to advance the therapeutic landscape for birth asphyxia worldwide. 

National institute for child health and human disease

We are working with Omniox, Inc. on a Fast Track Phase I/II SBIR award to develop a novel oxygen delivery biotherapeutic to help minimize the cardiac dysfunction associated with cardiopulmonary bypass in infants undergoing corrective repair of their congenital heart defects. 

iota Biosciences

In partnership with iota, we are developing vanishingly small implantable oxygen sensors for the chronic monitoring of tissue oxygenation in the setting of critical illness.

DEPARTMENT of DEFENSE

In partnership with the DOD, we are developing oxygen delivery biotherapeutics for the treatment of hemorrhagic shock.